US 8,444,991 · Application 12/532,225 · Granted May 21, 2013
US 8,444,991
Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
Estimated expiration
February 14, 2030
3y 141d remaining
Earliest effective filing
Mar 18, 2008
+ 20 years
Mar 18, 2028
PTA +698d
Feb 14, 2030
No TD
—
Final
Feb 14, 2030
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- January 29, 2010
- Earliest effective filing
- March 18, 2008
- Issue date
- May 21, 2013
- PTA
- +698 days
- Base expiry (before PTA)
- March 18, 2028
March 18, 2008 + 20 years = March 18, 2028 + 698 PTA days = February 14, 2030
- National stage entry of application PCTUS2008057355, filed Mar 18, 2008
- PRO60/896,429 — Provisional — not used for base term
- PRO60/896,429 — Provisional — not used for base term
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 12/532,225 · US 8,444,991
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 8,444,991: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US8444991Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.